Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 2/2010

01-02-2010 | Nuclear Medicine

Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT

Authors: Koichiro Kaneko, Koichiro Abe, Shingo Baba, Yoshitaka Tanabe, Hidetake Yabuuchi, Masamitsu Hatakenaka, Masayuki Sasaki, Hiroshi Honda

Published in: European Radiology | Issue 2/2010

Login to get access

Abstract

Objective

The aim of this study was to clarify the predictive significance of nodal calcification in terms of the therapeutic option of 131I therapy in papillary thyroid carcinoma (PTC) patients.

Methods

We reviewed 19 computed tomography (CT) examinations of PTC patients on receiving 131I therapy for the presence of nodal calcification, and compared the 131I whole-body scintigraphy and 18F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/CT findings. The metastatic lymph nodes (mLNs) were divided into three groups: A, those with calcification; B, those without calcification but belonging to patients who had calcified mLNs; C, those without calcification and belonging to patients who had no calcified mLNs. The incidences of 131I accumulation and maximum standardised uptake values (SUV max) in the three groups were compared.

Results

A total of 70 mLNs were evaluated. Twelve mLNs belonged to group A, 13 to group B and 45 to group C. The incidences of 131I accumulation were significantly higher in groups A (100%) and B (100%) than in group C (11.1%) (p < 0.0001 for both). The SUVmax was significantly lower in groups A (4.1 ± 1.9) and B (3.9 ± 1.4) than in group C (7.1 ± 4.4) (p = 0.01, p = 0.002, respectively).

Conclusions

Our results indicated that calcification in mLNs related to the ability of 131I accumulation and less dedifferentiation.
Literature
1.
Lam AK, Lo CY, Lam KS (2005) Papillary carcinoma of thyroid: a 30-yr clinicopathological review of the histological variants. Endocr Pathol 16:323–330CrossRefPubMed
2.
Wang N, Xu Y, Ge C et al (2006) Association of sonographically detected calcification with thyroid carcinoma. Head Neck 28:1077–1083CrossRefPubMed
3.
Hoang JK, Lee WK, Lee M et al (2007) US Features of thyroid malignancy: pearls and pitfalls. Radiographics 27:847–860CrossRefPubMed
4.
Fish SA, Langer JE, Mandel SJ (2008) Sonographic imaging of thyroid nodules and cervical lymph nodes. Endocrinol Metab Clin N Am 37:401–417CrossRef
5.
Shetty SK, Maher MM, Hahn PF et al (2006) Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 187:1349–1356CrossRefPubMed
6.
Chan JK (1990) Papillary carcinoma of thyroid: classical and variants. Histol Histopathol 5:241–257PubMed
7.
Machens A, Hinze R, Thomusch O et al (2002) Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22–28CrossRefPubMed
8.
Mirallié E, Sagan C, Hamy A et al (1999) Predictive factors for node involvement in papillary thyroid carcinoma. Univariate and multivariate analyses. Eur J Cancer 35:420–423CrossRefPubMed
9.
Wada N, Duh QY, Sugino K et al (2003) Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399–407CrossRefPubMed
10.
Mittendorf EA, Wang X, Perrier ND et al (2007) Follow up of patients with papillary thyroid cancer: in search of the optimal algorithm. J Am Coll Surg 205:239–247CrossRefPubMed
11.
Ahuja AT, Chow L, Chick W et al (1995) Metastatic cervical nodes in papillary carcinoma of the thyroid: ultrasound and histological correlation. Clin Radiol 50:229–231CrossRefPubMed
12.
Rosário PW, de Faria S, Bicalho L et al (2005) Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma. J Ultrasound Med 24:1385–1389PubMed
13.
Langer JE, Mandel SJ (2008) Sonographic imaging of cervical lymph nodes in patients with thyroid cancer. Neuroimaging Clin N Am 18:479–489CrossRefPubMed
14.
Som PM, Brandwein M, Lidov M et al (1994) The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings. Am J Neuroradiol 15:1123–1128PubMed
15.
Pacini F, Cetani F, Miccoli P et al (1994) Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 18:600–604CrossRefPubMed
16.
Woodrum DT, Gauger PG (2005) Role of 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol 89:114–121CrossRefPubMed
17.
Feine U, Lietzenmayer R, Hanke JP et al (1996) Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37:1468–1472PubMed
18.
Wang W, Macapinlac H, Larson SM et al (1999) [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels. J Clin Endocrinol Metab 84:2291–2302CrossRefPubMed
19.
Wang W, Larson SM, Tuttle RM et al (2001) Resistance of [18F]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid 11:1169–1175CrossRefPubMed
20.
van den Brekel MW, Stel HV, Castelijns JA et al (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379–384PubMed
21.
Khoo ML, Asa SL, Witterick IJ et al (2002) Thyroid calcification and its association with thyroid carcinoma. Head Neck 24:651–655CrossRefPubMed
22.
Merino MJ, Middleton LP (2001) Pathology of thyroid. In: Pilch BZ (ed) Head and neck surgical pathology. Lippincott and Williams & Wilkins, Philadelphia, pp 358–363
23.
Ellison E, Lapuerta P, Martin SE (1998) Psammoma bodies in fine-needle aspirates of the thyroid: predictive value for papillary carcinoma. Cancer 84:169–175CrossRefPubMed
24.
Eisenkraft BL, Som PM (1999) The spectrum of benign and malignant etiologies of cervical node calcification. AJR Am J Roentgenol 172:1433–1437PubMed
25.
Shammas A, Degirmenci B, Mountz JM et al (2007) 18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer. J Nucl Med 48:221–226PubMed
26.
Moog F, Linke R, Manthey N et al (2000) Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nucl Med 41:1989–1995PubMed
27.
Chin BB, Patel P, Cohade C et al (2004) Recombinant human thyrotropin stimulation of fluoro-D-glucose positron emission tomography uptake in well-differentiated thyroid carcinoma. J Clin Endocrinol Metab 89:91–95CrossRefPubMed
28.
Ma C, Kuang A, Xie J, Ma T (2005) Possible explanations for patients with discordant findings of serum thyroglobulin and 131I whole-body scanning. J Nucl Med 46:1473–1480PubMed
29.
Wang W, Larson SM, Fazzari M et al (2000) Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107–1113CrossRefPubMed
30.
Schoder H, Yeung HW (2004) Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med 34:180–197CrossRefPubMed
Metadata
Title
Can calcification predict 131I accumulation on metastatic lymph nodes in papillary thyroid carcinoma patients receiving 131I therapy? Comparison of CT, 131I WBS and 18F-FDG PET/CT
Authors
Koichiro Kaneko
Koichiro Abe
Shingo Baba
Yoshitaka Tanabe
Hidetake Yabuuchi
Masamitsu Hatakenaka
Masayuki Sasaki
Hiroshi Honda
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
European Radiology / Issue 2/2010
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-009-1557-5

Other articles of this Issue 2/2010

European Radiology 2/2010 Go to the issue

Experimental

Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T

Breast

US-guided diffused optical tomography: a promising functional imaging technique in breast lesions

Breast

The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study

Breast

Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment

Musculoskeletal

The in vivo effects of unloading and compression on T1-Gd (dGEMRIC) relaxation times in healthy articular knee cartilage at 3.0 Tesla

Interpretation Corner

An incidental nonfunctioning mediastinal paragaglioma (2009: 11b)